Search

The article discusses work by researchers at RMIT University on connections between cardiovascular disease and eye disease. Topics include the development of age-related macular degeneration (AMD), the role of glycosaminoglycans (GAGs) in AMD, and the role of Vascular Endothelial Growth Factor (VEGF) in AMD.

The article focuses on the Healthy Vision Month and the care of the eyes to prevent age-related macular degeneration, which great affects most age-old Americans.

The article reports on age-related macular degeneration (AMD) and the inclusion of genetics and environmental considerations in prediction models and the development of personalized medicine.

The article reports on the possible increased risk of malpractice among optometrists in diagnosing and managing age-related macular degeneration (AMD) resulting from advances in technology and therapeutics, according to optometrist Jerome Sherman.

The article discusses several research studies on health and wellness, including eye drops developed by scientists to pre-empt epidemic keratoconjunctivitis (EKC), the link between physical exercise and breast-cancer survival, and the link between aspirin and age-related macular degeneration.

The article focuses on a poster presentation by Doctor Baruch D. Kuppermann and colleagues which showed that volociximab, an alpha-5 beta-1 integrin antagonist, along with ranibizumab treatments for wet age-related macular degeneration has a favorable safety profile in early phase 1 studies. According to Doctor Kupperman, there was no evidence of dose-limiting toxicity or drug-related adverse events after dose escalation.

The article discusses a study by Jason S. Ehlrich and colleagues on the association of C5 1802V polymorphism and the risk of age-related macular degeneration (AMD). The study examined DNA sample results from AMD patients who had choroidal neovascularization. It was found that the genotype at C5 tended to have worse visual acuity loss in patients who underwent photodynamic therapy/sham treatment.

The article reports on the effectiveness of ciliary neurotrophic factor in reducing the size of geographic atrophy in dry age-related macular degeneration patients. Interim results from a phase 2 study presented by Carmen A. Puliafito at the 2008 American Academy of Ophthalmology meeting shows promising biologic trends in decreasing area of geographic atrophy and increasing optical coherence tomography (OCT) macular volume.